1964; Shojania tk
; Roberts, Arrowsmith, Rau & MonkJones, 1969 ). The development of low blood folate concentrations in these infants can be prevented by the intramuscular injection of IOO ,ug pteroylmonoglutamic acid on alternate days for the first 4 weeks of life (Burland, Simpson tk Lord, 1971 ).
The dietary folate requirements of full-term newborn infants have been said to be from 20 to 50 pg/d (Matoth et al. Sullivan, Luhby & Streiff, 1966) . Vanier & Tyas (1967) suggested that pre-term infants require more. Ford & Scott (1968) found that human and cow's milk contain approximately 50 ng total folate/ml. Ford & Scott (1968) and Burland et al. (1971) found the total folate content of proprietary milks prepared for infant feeding in the United Kingdom to be from 30 to 70 ng/ml, but on heating some of this folate may be destroyed. Burland et al. (1971) calculated that infants of low birth weight were likely to receive less than 15 pg folate/d from their diet at I week of age.
Though most of the folate in milk is in the free monoglutamate form, some is present as pteroylpolyglutamate. It was decided to investigate the ability of newborn infants of low birth weight to absorb pteroylmonoglutamic acid and pteroylpolyglutamate. In addition, we have attempted to determine the amount of orally administered folate necessary to prevent very low blood folate concentrations developing in these infants. 
E X P E R I M E N T A L
Forty-five healthy infants weighing less than 2-5 kg at birth were entered consecutively into one of three groups. One group received a supplement of 50 j i g pteroylmonoglutamic acid in solution daily by mouth, another j o pg pteroylpolyglutamates in solution and the third remained untreated, The supplement was given with the early evening feed on each of the first 14 d of life. All the infants received the same milk food prepared from a commercially available evaporated milk. Blood samples were taken for serum and red cell folate assay on the 1st day before the first feed and again 14 d later, as an indication of the absorption of the administered folate.
Pteroylpolyglutamates were prepared according to the method of Perry & Chanarin (1968). T h e folate content of the pteroylpolyglutamates was assayed by the method of Hoffbrand & Peters (1969) . Serum folate was determined according to the method described by Waters & Mollin (1961) and red cell folate concentrations by the method of Hoffbrand, Newcombe & Mollin (1966) . Estimation of the folate content of the milk given to all the infants in the trial was made by the method of Butterworth, Santini & Frommeyer (1963) .
R E S U L T S
The gestational age, sex and birth weights of the thirty-six infants who completed the study are shown in Table I . Some infants failed to complete the study because of intercurrent illness involving additional treatment during the course of the investigation or because of our inability to obtain adequate volumes of blood for serum folate assays at 14 d. Insufficient blood lvas available to dctcrmine red cell folate concentrations at 14 d in some infants includcd in the find analysis.
Serum and red cell folate concentrations
The serum and red cell folate concentrations on days I and 14 in each of the three groups of infants arc shown in Fig. I and Table 2 . The concentrations of serum and red cell folate on day I did not differ significantly between the three groups (Student's t test). Thcre appeared to be no rclationship between the folate Concentrations and whether or not the mother had received pteroylmonoglutamic acid during pregnancy. Nor did there appear to be a relationship with birth weight or gestational age.
Serum folate concentrations fell significantly in all three groups by day 14. The fall was most significant in the untreated group; three of ninc infants had a concentration less than 6 ng/ml at 14 d -t h a t is, bellow the normal range for the method of assay (Waters & Mollin, 1961) . Serum folate in one infant was less than 4 ng/ml; at this concentration there is believed to be a greatly increased risk of ensuing megaloblastic anaemia. There was no significant fall in red cell folate in any group. Table 3 compares the rate of fall of serum and red cell folate in the three groups of infants. There was a significant difference in the rate of fall of serum folate betwccn the treated groups and the untreated group but no difference between the two groups who received treatment. There was no difference in the rate of change in red cell folate when the groups were compared with each other.
Milk folate concentrations
The total folate activity of the evaporated milk given to the infants throughout the investigation was 49 ng/ml and the free folate activity was 42 ng/ml. At 14 d, an infant weighing 2 kg at birth might therefore be expected to receive 19 pg/d of folate from milk, of which 16 pg were in the free monoglutamate form.
D I S C U S S I O N
T h e values obtained for serum folate in the groups of infants indicate that pteroylpolyglutamate is absorbed in the newborn infant of low birth weight. This suggests that these infants do not lack jejunal pteroylpolyglutamate hydrolase, the enzyme thought to be involved in the absorption of dietary pteroylpolyglutamate.
The considerable fall in serum folate concentrations in untreated infants during the first 14 d of life was confirmed. The administration of 50 ,ug pteroylmonoglutamic acid or pteroylpolyglutamate did not prevent a fall occurring but resulted in significantly higher concentration of folate in the serum at 14 d. All but one of the untreated infants had serum folate concentrations at or below the concentrations found in treated infants (8 ngiml).
A fall in red cell folate concentration can only be expected after a considerably longer Vol. 30
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period of exposure to low serum folate concentrations than was experienced in this study.
The recommended daily requirement for normal infants up to the age of 6 months is 40 1.8 pteroylmonoglutamic acid (WHO, 1970). Our findings suggest that an oral supplement of 50pg folate daily is sufficient to prevent infants of low birth weight developing subnormal blood folate concentrations.
Conclusions
Newborn infants of low birth weight are able to absorb both monoglutamate and polyglutamate forms of folate, however, these infants have a requirement for folate in excess of the amount they are likely to receive in their diet. Since blood folate concentrations remain low for at least 3 months in such infants, it may be justified to advise giving a 50 pg daily supplement of pteroylmonoglutamic acid. Alternatively, milks intended for infant feeding could be fortified so that they ensure a total folate intake of at least 70 pg daily.
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